Ketamine Therapy Cost Breakdown: What You Will Actually Pay

Ketamine therapy for depression, anxiety, and treatment-resistant depression costs anywhere from about $2,000 to more than $10,000 in the first year, depending on the delivery method, dosing schedule, and whether insurance covers any part of treatment. IV ketamine infusions run the highest at $400 to $800 per session, at-home oral ketamine programs typically cost $150 to $400 per month, and Spravato (esketamine) nasal spray can range from a few hundred dollars a year with insurance to $20,000 or more without it. This ketamine therapy cost breakdown walks through pricing for every major treatment format, the hidden fees clinics don't always list upfront, and practical ways to lower your total bill.

Ketamine is a dissociative anesthetic that, at lower doses, has shown rapid antidepressant effects in clinical studies. It is administered clinically as an IV infusion, an intramuscular injection, a compounded oral or sublingual lozenge, or as Spravato, the FDA-approved esketamine nasal spray. Because most forms of ketamine used for depression are prescribed off-label, standard health insurance rarely covers them, which is why understanding true costs matters before you start treatment.

IV Ketamine Infusion Costs

IV (intravenous) ketamine infusions are the most established clinical form of ketamine therapy and are administered at specialized ketamine clinics under medical supervision. They are also the most expensive option covered in this ketamine therapy cost breakdown.

Per-Session Pricing

A single IV ketamine infusion typically costs $400 to $800, with a national average around $500 to $600. Price depends on your location (major metro areas tend to charge more), clinic overhead, the medical team's experience, and whether the session bundles integration therapy or enhanced monitoring. Many clinics charge $600 to $1,000 for the first session because it includes an extended medical evaluation, screening bloodwork, and a longer consultation. See what a typical visit involves in our IV infusion experience guide.

Initial Treatment Series

Most IV ketamine protocols call for an initial series of 6 infusions over 2 to 3 weeks, which brings the induction phase to $2,400 to $4,800 at typical pricing. This series is how your provider determines whether you are a responder, someone who experiences meaningful improvement from ketamine. Research summarized by the National Institute of Mental Health indicates that roughly 60 to 70 percent of patients with treatment-resistant depression show significant improvement during this initial series.

Maintenance Infusions

Patients who respond well typically move to periodic maintenance infusions to sustain benefits. Common schedules start with monthly sessions, extend to every 6 to 8 weeks, and sometimes taper to quarterly visits. Annual maintenance costs for IV ketamine typically range from $2,400 to $6,000 depending on how often you need sessions; extending the interval between infusions over time can lower long-term costs.

Total First-Year Cost: IV Ketamine

Combining the initial series and maintenance infusions, expect a first-year total of roughly $5,000 to $10,000 for IV ketamine therapy, and potentially more in premium markets or at clinics offering extensive ancillary services.

At-Home Oral Ketamine Costs

At-home oral ketamine programs, typically coordinated through telehealth platforms, are the most affordable format in this ketamine therapy cost breakdown. These programs prescribe sublingual (under-the-tongue) lozenges or tablets you take at home, usually with a companion present for safety. For more on how this compares to other formats, see our oral vs. sublingual ketamine guide.

Monthly Program Costs

Most at-home programs charge a monthly fee of $150 to $400 that covers the initial psychiatric evaluation, the ketamine prescription shipped to your door, ongoing telehealth visits with a prescriber, and clinical support between sessions. Some programs bundle everything into one flat fee; others bill medication separately. The compounded sublingual lozenge itself typically costs $50 to $150 per month through a compounding pharmacy.

Initial Evaluation

Many telehealth providers charge a one-time evaluation fee of $200 to $350 for the initial psychiatric assessment, though some fold this into the first month's fee. This evaluation determines whether ketamine is appropriate for you and sets your starting dose.

Treatment Protocol and Total First-Year Cost

A common at-home protocol involves 2 to 3 sessions per week during the first month, tapering to 1 to 2 sessions weekly in months two and three, then a maintenance schedule of 1 to 4 sessions per month. First-year costs for a typical at-home program run approximately $2,000 to $5,000, making it significantly cheaper than IV infusions. The two approaches are not clinically interchangeable, though: IV ketamine reaches higher blood levels more quickly and may work better for some patients with severe treatment-resistant depression.

Spravato (Esketamine) Costs

Spravato is the brand name for esketamine, a nasal spray form of ketamine that the FDA approved for treatment-resistant depression and for major depressive disorder with suicidal ideation. According to the FDA's approval announcement, Spravato must be administered in a certified healthcare setting with monitoring after each dose. It is also the only form of ketamine therapy commonly covered by insurance. See how it compares to generic ketamine in our ketamine vs. esketamine breakdown, or read a patient's Spravato nasal spray experience.

Without Insurance

Without coverage, Spravato is the most expensive option in this ketamine therapy cost breakdown. List price runs about $600 to $900 per session, and each dose requires a 2-hour monitoring period in a certified facility. The treatment schedule starts with twice-weekly sessions for the first month, then weekly sessions through month four, then weekly or every-other-week sessions ongoing. Without insurance, total first-year costs can exceed $20,000 to $30,000.

With Insurance

Many commercial insurance plans and Medicare cover Spravato once a patient has documented failure on at least two traditional antidepressants. Out-of-pocket costs with insurance vary by plan but typically range from $10 to $200 per session after you meet your deductible. The manufacturer also offers a patient savings program that can lower costs for eligible commercially insured patients.

Total First-Year Cost: Spravato

With insurance: roughly $500 to $5,000, depending on your coverage and deductible. Without insurance: $20,000 to $30,000 or more, making Spravato the least affordable option when coverage isn't available.

Intramuscular (IM) Ketamine Costs

Intramuscular ketamine injections are offered at some clinics as an alternative to IV infusions. Per-session pricing is generally lower, typically $300 to $600, because administration is simpler and doesn't require an IV setup. IM ketamine produces effects similar to IV infusions with a somewhat different onset and duration. First-year costs for IM ketamine, including the initial series and maintenance, typically run $4,000 to $8,000, comparable to the lower end of IV infusion pricing.

Hidden Costs to Consider

Budget for expenses beyond the sessions themselves. Initial evaluation fees may be billed separately from treatment, adding $200 to $500 to your upfront cost; our first appointment checklist covers what to expect. Lab work or medical clearance, particularly for patients with cardiovascular risk factors, can add $100 to $300 if not covered by insurance. You cannot drive after a ketamine session, so factor in rideshare fares, a companion's time, or taxi costs for every in-person visit. Lost work time is a real cost too, especially during the intensive initial phase of IV infusions, when 6 sessions in 2 to 3 weeks each require several hours of travel and recovery. Integration therapy, while not strictly required, adds $100 to $250 per session if it isn't already included in your program; many clinicians consider it important for sustaining treatment benefits. Learn more in our integration therapy guide.

Whether you're comparing IV clinics or telehealth programs, get these answers in writing before you commit. For a longer list of questions covering safety and continuity of care, see our guide on questions to ask a ketamine provider.

Strategies for Reducing Costs

Payment Plans and Financing

Many clinics offer payment plans or work with medical financing companies that let you spread costs over several months. Read the interest terms carefully before committing.

Package Pricing

Some clinics discount rates when you purchase a package of sessions upfront, typically 10 to 20 percent off the per-session price. This can produce meaningful savings if you're confident you'll complete the full series.

HSA and FSA Accounts

Health Savings Accounts and Flexible Spending Accounts can often be used to pay for ketamine therapy, since it's a medical treatment prescribed by a licensed provider. Confirm eligibility with your plan administrator and keep detailed receipts.

Insurance Appeals for IV Ketamine

Most insurance plans don't routinely cover IV ketamine, but some patients have successfully appealed denials, particularly when they document failure on multiple traditional antidepressants and include a letter of medical necessity from their prescribing provider. Success rates vary, but it's worth attempting if cost is a major barrier. Our insurance coverage guide covers what documentation tends to help.

Comparing Treatment Models

If IV infusions are financially out of reach, ask your provider about at-home oral ketamine programs. The clinical experience differs, but research supports the efficacy of oral and sublingual ketamine for many patients, and the cost difference is substantial.

Is Ketamine Therapy Worth the Cost?

Whether ketamine therapy is worth its cost depends on your financial situation, the severity of your condition, and how you've responded to other treatments. For many patients with treatment-resistant depression, the cost compares favorably to years of medications that didn't work, the lost productivity tied to untreated depression, and the emergency medical costs that severe depression can generate. As noted above, an estimated 60 to 70 percent of patients with treatment-resistant depression experience significant improvement with ketamine therapy, according to research summarized by the National Institute of Mental Health. For those patients, the return on investment in quality of life and reduced healthcare utilization can be substantial.

That said, ketamine therapy is not guaranteed to work for everyone, and the financial burden is real. Have an honest conversation with your provider about costs, expected outcomes, and a realistic treatment timeline before you begin. If you're just starting to research your options, our getting started guide is a good next step.